ArticleOrthopaedic journal of sports medicine2025
Fibrin Scaffold With Concentrated Growth Factor and Stromal Vascular Fraction: A Novel Approach for Repairing Chronic Rotator Cuff Tears in a Rabbit Model.
Article in Orthopaedic journal of sports medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Rotator cuff tears (RCTs) represent a significant challenge in orthopaedic care, particularly in chronic cases where tendon healing is suboptimal. Novel biological therapies such as concentrated growth factor (CGF) and stromal vascular fraction (SVF) offer promising solutions for enhanced tendon repair. Hypothesis: This study hypothesized that a fibrin scaffold enriched with CGF and SVF would improve tendon healing by reducing fatty degeneration, increasing vascularization, and enhancing biomechanical properties in a chronic RCT rabbit model. Study Design: Controlled laboratory study. Methods: A chronic RCT model was developed in the subscapularis tendon of 28 male New Zealand rabbits. In the first phase (week 0), the chronic injury model was created surgically. At week 6, in addition to the transosseous repair technique, biological materials were applied into the bone tunnel in each group as follows: hydrogel (group 1), fibrin gel with CGF (group 2), CGF+SVF-enriched fibrin scaffold (group 3), and no repair (group 4). At week 12, animals were euthanized, and samples were collected for macroscopic, histological, immunohistochemical, and biomechanical analysis. Results: Group 3 demonstrated a superior result. Fatty degeneration was significantly lower in group 3 compared with group 1 ( Conclusion: The inclusion of CGF and SVF in fibrin scaffolds significantly enhances tendon healing in chronic RCTs, outperforming the use of CGF alone. This combined biological approach offers a promising therapeutic strategy to optimize tendon repair outcomes. Clinical Relevance: These findings support the clinical potential of CGF and SVF in improving repair outcomes in chronic RCT cases in sports medicine.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.